Segment Reporting (Tables)

12 Months Ended

Dec. 31, 2016

Segment Reporting [Abstract]

Reconciliation of Revenue from Segments to Consolidated [Table Text Block]

A reconciliation of the totals reported for the reportable segments to the applicable line items in our accompanying consolidated statements of operations is as follows:

	Year Ended December 31,
(in millions)	2016			2015			2014
Net sales
Interventional Cardiology	$	2,524		$	2,242		$	2,092
Peripheral Interventions	1,093			975			861
Cardiovascular	3,617			3,217			2,953
Cardiac Rhythm Management	1,994			1,934			1,922
Electrophysiology	261			248			228
Rhythm Management	2,255			2,182			2,150
Endoscopy	1,565			1,422			1,343
Urology and Pelvic Health	1,065			735			542
Neuromodulation	574			512			474
MedSurg	3,204			2,669			2,359
Net sales allocated to reportable segments	9,076			8,068			7,462
Sales generated from business divestitures	—			—			4
Impact of foreign currency fluctuations	(690		)	(591		)	(86		)
	$	8,386		$	7,477		$	7,380

Reconciliation of depreciation by reportable segment to total [Table Text Block]

	Year Ended December 31,
(in millions)	2016			2015			2014
Depreciation expense
Cardiovascular	$	122		$	116		$	120
Rhythm Management	83			94			92
MedSurg	74			73			75
Depreciation expense allocated to reportable segments	279			283			287
Impact of foreign currency fluctuations	(9		)	(9		)	—
	$	270		$	274		$	287

Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]

	Year Ended December 31,
(in millions)	2016			2015			2014
Income (loss) before income taxes
Cardiovascular	$	1,137		$	972		$	767
Rhythm Management	404			328			289
MedSurg	1,045			856			746
Operating income allocated to reportable segments	2,586			2,156			1,802
Corporate expenses and currency exchange	(565		)	(486		)	(308		)
Intangible asset impairment charges; pension termination charges; and acquisition- and divestiture-related net charges, litigation-related net charges, and restructuring- and restructuring-related net charges	(1,029		)	(1,502		)	(1,357		)
Amortization expense	(545		)	(495		)	(438		)
Operating income (loss)	447			(327		)	(301		)
Other expense, net	(270		)	(323		)	(208		)
	$	177		$	(650	)	$	(509	)

Reconciliation of Assets from Segment to Consolidated [Table Text Block]

	As of December 31,
(in millions)	2016		2015
Total assets
Cardiovascular	$	1,748	$	1,583
Rhythm Management	1,250		1,279
MedSurg	1,499		1,141
Total assets allocated to reportable segments	4,497		4,003
Goodwill	6,678		6,473
Other intangible assets, net	5,883		6,194
All other corporate assets	1,038		1,463
	$	18,096	$	18,133

Reconciliation of sales by division and region to consolidated [Table Text Block]

Enterprise-Wide Information (based on actual currency exchange rates)

	Year Ended December 31,
(in millions)	2016		2015		2014
Net sales
Interventional Cardiology	$	2,281	$	2,033	$	2,057
Cardiac Rhythm Management	1,850		1,807		1,912
Endoscopy	1,440		1,306		1,323
Peripheral Interventions	1,011		904		850
Urology and Pelvic Health	1,005		693		535
Neuromodulation	556		501		472
Electrophysiology	243		233		227
	8,386		7,477		7,376
Sales generated from divested businesses	—		—		4
	$	8,386	$	7,477	$	7,380
United States	$	4,759	$	4,229	$	3,885
Japan	750		602		678
Other countries	2,877		2,646		2,813
	8,386		7,477		7,376
Sales generated from divested businesses	—		—		4
	$	8,386	$	7,477	$	7,380

Schedule of Disclosure on Geographic Areas, Long-Lived Assets in Individual Foreign Countries by Country [Table Text Block]

	As of December 31,
(in millions)	2016		2015		2014
Long-lived assets
United States	$	1,082	$	1,018	$	1,002
Ireland	181		170		197
Other foreign countries	367		302		308
Property, plant and equipment, net	1,630		1,490		1,507
Goodwill	6,678		6,473		5,898
Other intangible assets, net	5,883		6,194		5,606
	$	14,191	$	14,157	$	13,011